Key Segments:
By Type
-
HSV-1/HSV-2 Combines
-
HSV-1
-
HSV-2
By Sample Type
-
Blood
-
Swabs
-
Cerebrospinal fluid
By Test Type
-
Serological tests
-
Direct detection tests
-
PCR
-
Viral culture
-
-
Point-of-care tests
By End Use
-
Hospitals
-
Diagnostic laboratories
-
Clinics and sexual health centers
-
Home care / self-testing
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The HSV Testing Market is expected to grow at a CAGR of 6.12% from 2026 to 2035.
The HSV Testing Market was valued at USD 0.66 Billion in 2025.
Increasing STI prevalence awareness, expanding screening initiatives, and molecular diagnostic adoption are driving steady HSV testing demand.
The serological tests segment dominated the HSV Testing Market with 49.80% share in 2025.
North America dominated the HSV Testing Market in 2025.